Aratana Therapeutics prices upsized IPO at $6 per share

By
A A A

Aratana Therapeutics, which is developing medications for cats and dogs based on therapies for humans, raised $35 million by offering 5.8 million shares, 250,000 more than anticipated, at $6, in line with the lower revised price. The company had previously filed to offer 4.3 million shares at a range of $11 to $13 before cutting the deal size Wednesday morning. Aratana Therapeutics will list on the NASDAQ under the symbol PETX. Stifel and Lazard Capital Markets acted as lead managers on the deal.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: PETX

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Tiny Homes With Big Appeal
Tiny Homes With Big Appeal          

Stocks

Referenced

100%

Most Active by Volume

270,887,127
    $93.89 unch
225,243,115
  • $40.93 ▼ 2.74%
135,900,109
  • $47.52 ▲ 1.80%
89,467,924
  • $5.35 ▼ 1.11%
85,105,358
  • $16.95 ▼ 0.53%
80,748,539
  • $39.80 ▼ 4.21%
68,491,586
  • $3.57 ▼ 1.79%
62,097,356
  • $100.96 ▼ 0.82%
As of 9/19/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com